Product used for radioembolization for liver cancer

Ended Awarded Last action

Contract number
HT009026FJ029
Awardee
Awarding agency
Obligated
$20,580

Award facts

Contract value 100% obligated
$20,580.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Q517 Pharmacy Services
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Marlborough, MA 01752, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Boston Scientific Corp on May 22, 2026, for a product used in radioembolization for liver cancer, with a ceiling value of $20,580.00. The call is issued under the Defense Health Agency single-award Blanket Purchase Agreement, a $750,000 vehicle (awarded March 31, 2025, through March 30, 2030) under which Boston Scientific serves as sole supplier for radiation treatment devices and medical supplies. Place of performance is Marlborough, Massachusetts. The call is due for ultimate completion by September 30, 2026. Pricing is firm fixed price on a full-and-open basis with no set-aside applied.

Quick answers

Who was awarded contract HT009026FJ029?

HT009026FJ029 was awarded to Boston Scientific Corp by Defense Health Agency (Department of Defense) on May 22, 2026.

How much is contract HT009026FJ029 worth?

The government has obligated $20,580 on HT009026FJ029.

Is contract HT009026FJ029 an order under another contract?

Yes. HT009026FJ029 is a BPA call under HT001425A0008, a blanket purchase agreement.

Was contract HT009026FJ029 competed?

The extent of competition for HT009026FJ029 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award